Peptron Inc. is a CDMO of peptides based in South Korea. Direct manufacturer. Founded 1997. Key products include sustained-release medications, peptide synthesis services.
Listing reviewed September 2026.
Korean CDMO developing sustained-release peptide delivery technology. Founded 1997. Constructing new
Directory assessment: Peptron Inc. is listed as a CDMO in the peptide supply chain, serving Asia markets from South Korea. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.